Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management
- PMID: 18402533
- DOI: 10.1586/14779072.6.4.435
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management
Similar articles
-
Leptin in acute coronary syndromes: has the time come for its use in risk stratification?Int J Cardiol. 2008 Nov 12;130(2):264-5. doi: 10.1016/j.ijcard.2007.07.007. Epub 2007 Jul 31. Int J Cardiol. 2008. PMID: 17669522
-
The future of biomarkers in the management of patients with acute coronary syndromes.Curr Opin Cardiol. 2008 Jul;23(4):309-14. doi: 10.1097/HCO.0b013e3283021b24. Curr Opin Cardiol. 2008. PMID: 18520713 Review.
-
European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes.Resuscitation. 2010 Oct;81(10):1353-63. doi: 10.1016/j.resuscitation.2010.08.016. Resuscitation. 2010. PMID: 20956048 No abstract available.
-
Biomarkers in risk stratification of acute coronary syndromes: new insights into hematologic parameters.Rev Port Cardiol. 2009 Sep;28(9):925-7. Rev Port Cardiol. 2009. PMID: 19998804 English, Portuguese. No abstract available.
-
[Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].Arch Cardiol Mex. 2009 Jan-Mar;79(1):54-62. Arch Cardiol Mex. 2009. PMID: 19545076 Review. Spanish.
Cited by
-
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands.BMJ Open. 2016 Dec 23;6(12):e012929. doi: 10.1136/bmjopen-2016-012929. BMJ Open. 2016. PMID: 28011810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources